The global Drug-Device Combination Products market was valued at US$ 35200 million in 2023 and is anticipated to reach US$ 53720 million by 2030, witnessing a CAGR of 6.2% during the forecast period 2024-2030.

Drug-Device Combination Products Market

Combination products are therapeutic and diagnostic products that combine drugs, devices and/or biological products, leading to safer and more effective treatments thanks to careful and precise drug targeting, local administration and individualized therapy. These technologies can especially benefit patients suffering from serious diseases and conditions such as cancer, heart disease, multiple sclerosis and diabetes, among others. On the other hand, drug-device combination products have also introduced a new dynamic in medical product development, regulatory approval and corporate interaction.

Global key drug-device combination products players include GSK, Novo Nordisk and Eli Lilly etc. The top 3 companies hold a share about 32%. North America is the largset market with a share about 42%, followed by Europe and Asia-Pacific.

In terms of product, nebulizer & inhaler is the largest segment with a share about 36%. And in terms of applications, the largset application is hospital and clinic with a share about 47%.

This report aims to provide a comprehensive presentation of the global market for Drug-Device Combination Products, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug-Device Combination Products.

Report Scope

The Drug-Device Combination Products market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Drug-Device Combination Products market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug-Device Combination Products companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Drug-Device Combination Products Market Report

Report Metric	Details
Report Name	Drug-Device Combination Products Market
Accounted market size in 2023	US$ 35200 million
Forecasted market size in 2030	US$ 53720 million
CAGR	6.2%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Drug-Coated Device Prefilled Drug Delivery Systems Nebulizer and Inhaler Transdermal Delivery System Others
Segment by Application	Hospital andClinic Retail Pharmacies Other
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Mylan, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug-Device Combination Products companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Drug-Device Combination Products Market growing?

Ans: The Drug-Device Combination Products Market witnessing a CAGR of 6.2% during the forecast period 2024-2030.

What is the Drug-Device Combination Products Market size in 2030?

Ans: The Drug-Device Combination Products Market size in 2030 will be US$ 53720 million.

What is the market share of major companies in Drug-Device Combination Products Market?

Ans: The top 3 companies hold a share about 32%.

Who are the main players in the Drug-Device Combination Products Market report?

Ans: The main players in the Drug-Device Combination Products Market are GSK, Novo Nordisk, Eli Lilly, AstraZeneca, Sanofi, Boston Scientific, Abbott, Boehringer Ingelheim, Medtronic, Mylan, 3M, Hisamitsu, Smith & Nephew, Molnlycke, Teleflex, BD, Lepu Medical, MicroPort, Terumo, B. Braun, Antares Pharma

What are the Application segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Applications covered in the Drug-Device Combination Products Market report are Hospital andClinic, Retail Pharmacies, Other

What are the Type segmentation covered in the Drug-Device Combination Products Market report?

Ans: The Types covered in the Drug-Device Combination Products Market report are Drug-Coated Device, Prefilled Drug Delivery Systems, Nebulizer and Inhaler, Transdermal Delivery System, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Drug-Device Combination Products Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Drug-Coated Device

1.2.3 Prefilled Drug Delivery Systems

1.2.4 Nebulizer and Inhaler

1.2.5 Transdermal Delivery System

1.2.6 Others

1.3 Market by Application

1.3.1 Global Drug-Device Combination Products Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital andClinic

1.3.3 Retail Pharmacies

1.3.4 Other

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Drug-Device Combination Products Market Perspective (2019-2030)

2.2 Drug-Device Combination Products Growth Trends by Region

2.2.1 Global Drug-Device Combination Products Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Drug-Device Combination Products Historic Market Size by Region (2019-2024)

2.2.3 Drug-Device Combination Products Forecasted Market Size by Region (2025-2030)

2.3 Drug-Device Combination Products Market Dynamics

2.3.1 Drug-Device Combination Products Industry Trends

2.3.2 Drug-Device Combination Products Market Drivers

2.3.3 Drug-Device Combination Products Market Challenges

2.3.4 Drug-Device Combination Products Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Drug-Device Combination Products Players by Revenue

3.1.1 Global Top Drug-Device Combination Products Players by Revenue (2019-2024)

3.1.2 Global Drug-Device Combination Products Revenue Market Share by Players (2019-2024)

3.2 Global Drug-Device Combination Products Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Drug-Device Combination Products Revenue

3.4 Global Drug-Device Combination Products Market Concentration Ratio

3.4.1 Global Drug-Device Combination Products Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Drug-Device Combination Products Revenue in 2023

3.5 Drug-Device Combination Products Key Players Head office and Area Served

3.6 Key Players Drug-Device Combination Products Product Solution and Service

3.7 Date of Enter into Drug-Device Combination Products Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Drug-Device Combination Products Breakdown Data by Type

4.1 Global Drug-Device Combination Products Historic Market Size by Type (2019-2024)

4.2 Global Drug-Device Combination Products Forecasted Market Size by Type (2025-2030)

5 Drug-Device Combination Products Breakdown Data by Application

5.1 Global Drug-Device Combination Products Historic Market Size by Application (2019-2024)

5.2 Global Drug-Device Combination Products Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Drug-Device Combination Products Market Size (2019-2030)

6.2 North America Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Drug-Device Combination Products Market Size by Country (2019-2024)

6.4 North America Drug-Device Combination Products Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Drug-Device Combination Products Market Size (2019-2030)

7.2 Europe Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Drug-Device Combination Products Market Size by Country (2019-2024)

7.4 Europe Drug-Device Combination Products Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Drug-Device Combination Products Market Size (2019-2030)

8.2 Asia-Pacific Drug-Device Combination Products Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Drug-Device Combination Products Market Size by Region (2019-2024)

8.4 Asia-Pacific Drug-Device Combination Products Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Drug-Device Combination Products Market Size (2019-2030)

9.2 Latin America Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Drug-Device Combination Products Market Size by Country (2019-2024)

9.4 Latin America Drug-Device Combination Products Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Drug-Device Combination Products Market Size (2019-2030)

10.2 Middle East & Africa Drug-Device Combination Products Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Drug-Device Combination Products Market Size by Country (2019-2024)

10.4 Middle East & Africa Drug-Device Combination Products Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Detail

11.1.2 GSK Business Overview

11.1.3 GSK Drug-Device Combination Products Introduction

11.1.4 GSK Revenue in Drug-Device Combination Products Business (2019-2024)

11.1.5 GSK Recent Development

11.2 Novo Nordisk

11.2.1 Novo Nordisk Company Detail

11.2.2 Novo Nordisk Business Overview

11.2.3 Novo Nordisk Drug-Device Combination Products Introduction

11.2.4 Novo Nordisk Revenue in Drug-Device Combination Products Business (2019-2024)

11.2.5 Novo Nordisk Recent Development

11.3 Eli Lilly

11.3.1 Eli Lilly Company Detail

11.3.2 Eli Lilly Business Overview

11.3.3 Eli Lilly Drug-Device Combination Products Introduction

11.3.4 Eli Lilly Revenue in Drug-Device Combination Products Business (2019-2024)

11.3.5 Eli Lilly Recent Development

11.4 AstraZeneca

11.4.1 AstraZeneca Company Detail

11.4.2 AstraZeneca Business Overview

11.4.3 AstraZeneca Drug-Device Combination Products Introduction

11.4.4 AstraZeneca Revenue in Drug-Device Combination Products Business (2019-2024)

11.4.5 AstraZeneca Recent Development

11.5 Sanofi

11.5.1 Sanofi Company Detail

11.5.2 Sanofi Business Overview

11.5.3 Sanofi Drug-Device Combination Products Introduction

11.5.4 Sanofi Revenue in Drug-Device Combination Products Business (2019-2024)

11.5.5 Sanofi Recent Development

11.6 Boston Scientific

11.6.1 Boston Scientific Company Detail

11.6.2 Boston Scientific Business Overview

11.6.3 Boston Scientific Drug-Device Combination Products Introduction

11.6.4 Boston Scientific Revenue in Drug-Device Combination Products Business (2019-2024)

11.6.5 Boston Scientific Recent Development

11.7 Abbott

11.7.1 Abbott Company Detail

11.7.2 Abbott Business Overview

11.7.3 Abbott Drug-Device Combination Products Introduction

11.7.4 Abbott Revenue in Drug-Device Combination Products Business (2019-2024)

11.7.5 Abbott Recent Development

11.8 Boehringer Ingelheim

11.8.1 Boehringer Ingelheim Company Detail

11.8.2 Boehringer Ingelheim Business Overview

11.8.3 Boehringer Ingelheim Drug-Device Combination Products Introduction

11.8.4 Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2019-2024)

11.8.5 Boehringer Ingelheim Recent Development

11.9 Medtronic

11.9.1 Medtronic Company Detail

11.9.2 Medtronic Business Overview

11.9.3 Medtronic Drug-Device Combination Products Introduction

11.9.4 Medtronic Revenue in Drug-Device Combination Products Business (2019-2024)

11.9.5 Medtronic Recent Development

11.10 Mylan

11.10.1 Mylan Company Detail

11.10.2 Mylan Business Overview

11.10.3 Mylan Drug-Device Combination Products Introduction

11.10.4 Mylan Revenue in Drug-Device Combination Products Business (2019-2024)

11.10.5 Mylan Recent Development

11.11 3M

11.11.1 3M Company Detail

11.11.2 3M Business Overview

11.11.3 3M Drug-Device Combination Products Introduction

11.11.4 3M Revenue in Drug-Device Combination Products Business (2019-2024)

11.11.5 3M Recent Development

11.12 Hisamitsu

11.12.1 Hisamitsu Company Detail

11.12.2 Hisamitsu Business Overview

11.12.3 Hisamitsu Drug-Device Combination Products Introduction

11.12.4 Hisamitsu Revenue in Drug-Device Combination Products Business (2019-2024)

11.12.5 Hisamitsu Recent Development

11.13 Smith & Nephew

11.13.1 Smith & Nephew Company Detail

11.13.2 Smith & Nephew Business Overview

11.13.3 Smith & Nephew Drug-Device Combination Products Introduction

11.13.4 Smith & Nephew Revenue in Drug-Device Combination Products Business (2019-2024)

11.13.5 Smith & Nephew Recent Development

11.14 Molnlycke

11.14.1 Molnlycke Company Detail

11.14.2 Molnlycke Business Overview

11.14.3 Molnlycke Drug-Device Combination Products Introduction

11.14.4 Molnlycke Revenue in Drug-Device Combination Products Business (2019-2024)

11.14.5 Molnlycke Recent Development

11.15 Teleflex

11.15.1 Teleflex Company Detail

11.15.2 Teleflex Business Overview

11.15.3 Teleflex Drug-Device Combination Products Introduction

11.15.4 Teleflex Revenue in Drug-Device Combination Products Business (2019-2024)

11.15.5 Teleflex Recent Development

11.16 BD

11.16.1 BD Company Detail

11.16.2 BD Business Overview

11.16.3 BD Drug-Device Combination Products Introduction

11.16.4 BD Revenue in Drug-Device Combination Products Business (2019-2024)

11.16.5 BD Recent Development

11.17 Lepu Medical

11.17.1 Lepu Medical Company Detail

11.17.2 Lepu Medical Business Overview

11.17.3 Lepu Medical Drug-Device Combination Products Introduction

11.17.4 Lepu Medical Revenue in Drug-Device Combination Products Business (2019-2024)

11.17.5 Lepu Medical Recent Development

11.18 MicroPort

11.18.1 MicroPort Company Detail

11.18.2 MicroPort Business Overview

11.18.3 MicroPort Drug-Device Combination Products Introduction

11.18.4 MicroPort Revenue in Drug-Device Combination Products Business (2019-2024)

11.18.5 MicroPort Recent Development

11.19 Terumo

11.19.1 Terumo Company Detail

11.19.2 Terumo Business Overview

11.19.3 Terumo Drug-Device Combination Products Introduction

11.19.4 Terumo Revenue in Drug-Device Combination Products Business (2019-2024)

11.19.5 Terumo Recent Development

11.20 B. Braun

11.20.1 B. Braun Company Detail

11.20.2 B. Braun Business Overview

11.20.3 B. Braun Drug-Device Combination Products Introduction

11.20.4 B. Braun Revenue in Drug-Device Combination Products Business (2019-2024)

11.20.5 B. Braun Recent Development

11.21 Antares Pharma

11.21.1 Antares Pharma Company Detail

11.21.2 Antares Pharma Business Overview

11.21.3 Antares Pharma Drug-Device Combination Products Introduction

11.21.4 Antares Pharma Revenue in Drug-Device Combination Products Business (2019-2024)

11.21.5 Antares Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Mylan NV

Medtronic Inc

Boston Scientific

Teleflex

Terumo

List of Tables

Table 1. Global Drug-Device Combination Products Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Drug-Coated Device

Table 3. Key Players of Prefilled Drug Delivery Systems

Table 4. Key Players of Nebulizer and Inhaler

Table 5. Key Players of Transdermal Delivery System

Table 6. Key Players of Others

Table 7. Global Drug-Device Combination Products Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Drug-Device Combination Products Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 9. Global Drug-Device Combination Products Market Size by Region (2019-2024) & (US$ Million)

Table 10. Global Drug-Device Combination Products Market Share by Region (2019-2024)

Table 11. Global Drug-Device Combination Products Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 12. Global Drug-Device Combination Products Market Share by Region (2025-2030)

Table 13. Drug-Device Combination Products Market Trends

Table 14. Drug-Device Combination Products Market Drivers

Table 15. Drug-Device Combination Products Market Challenges

Table 16. Drug-Device Combination Products Market Restraints

Table 17. Global Drug-Device Combination Products Revenue by Players (2019-2024) & (US$ Million)

Table 18. Global Drug-Device Combination Products Market Share by Players (2019-2024)

Table 19. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2023)

Table 20. Ranking of Global Top Drug-Device Combination Products Companies by Revenue (US$ Million) in 2023

Table 21. Global 5 Largest Players Market Share by Drug-Device Combination Products Revenue (CR5 and HHI) & (2019-2024)

Table 22. Key Players Headquarters and Area Served

Table 23. Key Players Drug-Device Combination Products Product Solution and Service

Table 24. Date of Enter into Drug-Device Combination Products Market

Table 25. Mergers & Acquisitions, Expansion Plans

Table 26. Global Drug-Device Combination Products Market Size by Type (2019-2024) & (US$ Million)

Table 27. Global Drug-Device Combination Products Revenue Market Share by Type (2019-2024)

Table 28. Global Drug-Device Combination Products Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 29. Global Drug-Device Combination Products Revenue Market Share by Type (2025-2030)

Table 30. Global Drug-Device Combination Products Market Size by Application (2019-2024) & (US$ Million)

Table 31. Global Drug-Device Combination Products Revenue Market Share by Application (2019-2024)

Table 32. Global Drug-Device Combination Products Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 33. Global Drug-Device Combination Products Revenue Market Share by Application (2025-2030)

Table 34. North America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. North America Drug-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)

Table 36. North America Drug-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)

Table 37. Europe Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Europe Drug-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)

Table 39. Europe Drug-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)

Table 40. Asia-Pacific Drug-Device Combination Products Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 41. Asia-Pacific Drug-Device Combination Products Market Size by Region (2019-2024) & (US$ Million)

Table 42. Asia-Pacific Drug-Device Combination Products Market Size by Region (2025-2030) & (US$ Million)

Table 43. Latin America Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Latin America Drug-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)

Table 45. Latin America Drug-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)

Table 46. Middle East & Africa Drug-Device Combination Products Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 47. Middle East & Africa Drug-Device Combination Products Market Size by Country (2019-2024) & (US$ Million)

Table 48. Middle East & Africa Drug-Device Combination Products Market Size by Country (2025-2030) & (US$ Million)

Table 49. GSK Company Detail

Table 50. GSK Business Overview

Table 51. GSK Drug-Device Combination Products Product

Table 52. GSK Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 53. GSK Recent Development

Table 54. Novo Nordisk Company Detail

Table 55. Novo Nordisk Business Overview

Table 56. Novo Nordisk Drug-Device Combination Products Product

Table 57. Novo Nordisk Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 58. Novo Nordisk Recent Development

Table 59. Eli Lilly Company Detail

Table 60. Eli Lilly Business Overview

Table 61. Eli Lilly Drug-Device Combination Products Product

Table 62. Eli Lilly Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 63. Eli Lilly Recent Development

Table 64. AstraZeneca Company Detail

Table 65. AstraZeneca Business Overview

Table 66. AstraZeneca Drug-Device Combination Products Product

Table 67. AstraZeneca Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 68. AstraZeneca Recent Development

Table 69. Sanofi Company Detail

Table 70. Sanofi Business Overview

Table 71. Sanofi Drug-Device Combination Products Product

Table 72. Sanofi Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 73. Sanofi Recent Development

Table 74. Boston Scientific Company Detail

Table 75. Boston Scientific Business Overview

Table 76. Boston Scientific Drug-Device Combination Products Product

Table 77. Boston Scientific Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 78. Boston Scientific Recent Development

Table 79. Abbott Company Detail

Table 80. Abbott Business Overview

Table 81. Abbott Drug-Device Combination Products Product

Table 82. Abbott Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 83. Abbott Recent Development

Table 84. Boehringer Ingelheim Company Detail

Table 85. Boehringer Ingelheim Business Overview

Table 86. Boehringer Ingelheim Drug-Device Combination Products Product

Table 87. Boehringer Ingelheim Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 88. Boehringer Ingelheim Recent Development

Table 89. Medtronic Company Detail

Table 90. Medtronic Business Overview

Table 91. Medtronic Drug-Device Combination Products Product

Table 92. Medtronic Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 93. Medtronic Recent Development

Table 94. Mylan Company Detail

Table 95. Mylan Business Overview

Table 96. Mylan Drug-Device Combination Products Product

Table 97. Mylan Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 98. Mylan Recent Development

Table 99. 3M Company Detail

Table 100. 3M Business Overview

Table 101. 3M Drug-Device Combination Products Product

Table 102. 3M Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 103. 3M Recent Development

Table 104. Hisamitsu Company Detail

Table 105. Hisamitsu Business Overview

Table 106. Hisamitsu Drug-Device Combination Products Product

Table 107. Hisamitsu Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 108. Hisamitsu Recent Development

Table 109. Smith & Nephew Company Detail

Table 110. Smith & Nephew Business Overview

Table 111. Smith & Nephew Drug-Device Combination Products Product

Table 112. Smith & Nephew Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 113. Smith & Nephew Recent Development

Table 114. Molnlycke Company Detail

Table 115. Molnlycke Business Overview

Table 116. Molnlycke Drug-Device Combination Products Product

Table 117. Molnlycke Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 118. Molnlycke Recent Development

Table 119. Teleflex Company Detail

Table 120. Teleflex Business Overview

Table 121. Teleflex Drug-Device Combination Products Product

Table 122. Teleflex Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 123. Teleflex Recent Development

Table 124. BD Company Detail

Table 125. BD Business Overview

Table 126. BD Drug-Device Combination Products Product

Table 127. BD Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 128. BD Recent Development

Table 129. Lepu Medical Company Detail

Table 130. Lepu Medical Business Overview

Table 131. Lepu Medical Drug-Device Combination Products Product

Table 132. Lepu Medical Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 133. Lepu Medical Recent Development

Table 134. MicroPort Company Detail

Table 135. MicroPort Business Overview

Table 136. MicroPort Drug-Device Combination Products Product

Table 137. MicroPort Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 138. MicroPort Recent Development

Table 139. Terumo Company Detail

Table 140. Terumo Business Overview

Table 141. Terumo Drug-Device Combination Products Product

Table 142. Terumo Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 143. Terumo Recent Development

Table 144. B. Braun Company Detail

Table 145. B. Braun Business Overview

Table 146. B. Braun Drug-Device Combination Products Product

Table 147. B. Braun Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 148. B. Braun Recent Development

Table 149. Antares Pharma Company Detail

Table 150. Antares Pharma Business Overview

Table 151. Antares Pharma Drug-Device Combination Products Product

Table 152. Antares Pharma Revenue in Drug-Device Combination Products Business (2019-2024) & (US$ Million)

Table 153. Antares Pharma Recent Development

Table 154. Research Programs/Design for This Report

Table 155. Key Data Information from Secondary Sources

Table 156. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Drug-Device Combination Products Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Drug-Device Combination Products Market Share by Type: 2023 VS 2030

Figure 3. Drug-Coated Device Features

Figure 4. Prefilled Drug Delivery Systems Features

Figure 5. Nebulizer and Inhaler Features

Figure 6. Transdermal Delivery System Features

Figure 7. Others Features

Figure 8. Global Drug-Device Combination Products Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 9. Global Drug-Device Combination Products Market Share by Application: 2023 VS 2030

Figure 10. Hospital andClinic Case Studies

Figure 11. Retail Pharmacies Case Studies

Figure 12. Other Case Studies

Figure 13. Drug-Device Combination Products Report Years Considered

Figure 14. Global Drug-Device Combination Products Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 15. Global Drug-Device Combination Products Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 16. Global Drug-Device Combination Products Market Share by Region: 2023 VS 2030

Figure 17. Global Drug-Device Combination Products Market Share by Players in 2023

Figure 18. Global Top Drug-Device Combination Products Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drug-Device Combination Products as of 2023)

Figure 19. The Top 10 and 5 Players Market Share by Drug-Device Combination Products Revenue in 2023

Figure 20. North America Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. North America Drug-Device Combination Products Market Share by Country (2019-2030)

Figure 22. United States Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Canada Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Drug-Device Combination Products Market Share by Country (2019-2030)

Figure 26. Germany Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. France Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. U.K. Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Italy Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Russia Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Nordic Countries Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Drug-Device Combination Products Market Share by Region (2019-2030)

Figure 34. China Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. Japan Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. South Korea Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Southeast Asia Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. India Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Australia Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Drug-Device Combination Products Market Share by Country (2019-2030)

Figure 42. Mexico Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Brazil Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Drug-Device Combination Products Market Share by Country (2019-2030)

Figure 46. Turkey Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. Saudi Arabia Drug-Device Combination Products Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. GSK Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 49. Novo Nordisk Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 50. Eli Lilly Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 51. AstraZeneca Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 52. Sanofi Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 53. Boston Scientific Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 54. Abbott Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 55. Boehringer Ingelheim Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 56. Medtronic Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 57. Mylan Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 58. 3M Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 59. Hisamitsu Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 60. Smith & Nephew Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 61. Molnlycke Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 62. Teleflex Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 63. BD Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 64. Lepu Medical Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 65. MicroPort Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 66. Terumo Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 67. B. Braun Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 68. Antares Pharma Revenue Growth Rate in Drug-Device Combination Products Business (2019-2024)

Figure 69. Bottom-up and Top-down Approaches for This Report

Figure 70. Data Triangulation

Figure 71. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

120 Pages

Type: Report

Code: QYRE-Auto-19C17792

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Medical Electrode Patch - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-31N14423

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Anesthesia Replacement O2 Sensor - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-21H14583

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

Medical Self-Adhesive Electrodes - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages

Type: Report

Code: QYRE-Auto-26P14342

Tue Nov 12 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Drug-Device Combination Products Market Research Report 2024

Published Date: February 2024

Report Code: QYRE-Auto-33L12123

Global Drug-Device Combination Products Market Research Report 2024

FEATURED COMPANIES

Drug-Device Combination Products Market Size

Drug-Device Combination Products Market

Report Scope

Scope of Drug-Device Combination Products Market Report

Chapter Outline

FAQ for this report

How fast is Drug-Device Combination Products Market growing?

What is the Drug-Device Combination Products Market size in 2030?

What is the market share of major companies in Drug-Device Combination Products Market?

Who are the main players in the Drug-Device Combination Products Market report?

What are the Application segmentation covered in the Drug-Device Combination Products Market report?

What are the Type segmentation covered in the Drug-Device Combination Products Market report?

FEATURED COMPANIES

RELATED REPORTS